VBI Vaccines Inc. (NASDAQ: VBIV) open the trading on September 10, 2020, with a bit cautious approach as it glided -0.96% to $3.10. During the day, the stock rose to $3.24 and sunk to $3.075 before settling in for the price of $3.13 at the close. Taking a more long-term approach, VBIV posted a 52-week range of $0.47-$6.93.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 0.00%. This publicly-traded company’s shares outstanding now amounts to $231.20 million, simultaneously with a float of $150.88 million. The organization now has a market capitalization sitting at $716.71 million. At the time of writing, stock’s 50-day Moving Average stood at $4.06, while the 200-day Moving Average is $2.12.
It is quite necessary to find out the efficiency of the corporate organization, which has 123 number of employees on its payroll. It has generated 17,768 per worker during the last fiscal year. Meanwhile, its income per employee was -438,504. The stock had 17.28 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks gross margin was -310.09, operating margin was -2075.96 and Pretax Margin of -2467.94.
VBI Vaccines Inc. (VBIV) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. VBI Vaccines Inc.’s current insider ownership accounts for 5.26%, in contrast to 44.45% institutional ownership. According to the most recent insider trade that took place on Apr 24, this organization’s 10% Owner bought 9,090,909 shares at the rate of 1.10, making the entire transaction reach 10,000,000 in total value, affecting insider ownership by 55,042,456. Preceding that transaction, on Oct 04, Company’s Chief Medical Officer bought 40,000 for 0.50, making the whole transaction’s value amount to 20,000. This particular insider is now the holder of 117,500 in total.
VBI Vaccines Inc. (VBIV) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2018 suggests? It has posted -$0.26 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.19) by -$0.07. This company achieved a net margin of -2467.94 while generating a return on equity of -58.82. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
VBI Vaccines Inc.’s EPS decrease for this current 12-month fiscal period is 0.00% and is forecasted to reach -0.77 in the upcoming year.
VBI Vaccines Inc. (NASDAQ: VBIV) Trading Performance Indicators
Let’s observe the current performance indicators for VBI Vaccines Inc. (VBIV). The Stock has managed to achieve an average true range (ATR) of 0.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 393.80.
In the same vein, VBIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.27, a figure that is expected to reach -0.22 in the next quarter, and analysts are predicting that it will be -0.77 at the market close of one year from today.
Technical Analysis of VBI Vaccines Inc. (VBIV)
[VBI Vaccines Inc., VBIV] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 7.72% While, its Average True Range was 0.45.
Raw Stochastic average of VBI Vaccines Inc. (VBIV) in the period of the previous 100 days is set at 35.19%, which indicates a major rise in contrast to 9.09% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 153.08% that was higher than 133.90% volatility it exhibited in the past 100-days period.